These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17610909)

  • 1. Mathematical modeling and qualitative analysis of insulin therapies.
    Wang H; Li J; Kuang Y
    Math Biosci; 2007 Nov; 210(1):17-33. PubMed ID: 17610909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic insulin delivery with insulin feedback: a control systems perspective.
    Palerm CC
    Comput Methods Programs Biomed; 2011 May; 102(2):130-7. PubMed ID: 20674062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Improved PID Algorithm Based on Insulin-on-Board Estimate for Blood Glucose Control with Type 1 Diabetes.
    Hu R; Li C
    Comput Math Methods Med; 2015; 2015():281589. PubMed ID: 26550021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the glucose-insulin regulatory system and ultradian insulin secretory oscillations with two explicit time delays.
    Li J; Kuang Y; Mason CC
    J Theor Biol; 2006 Oct; 242(3):722-35. PubMed ID: 16712872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer model for mechanisms underlying ultradian oscillations of insulin and glucose.
    Sturis J; Polonsky KS; Mosekilde E; Van Cauter E
    Am J Physiol; 1991 May; 260(5 Pt 1):E801-9. PubMed ID: 2035636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural network modeling and control of type 1 diabetes mellitus.
    El-Jabali AK
    Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of different control techniques for the regulation of blood glucose level in diabetic patients.
    Ibbini MS
    J Med Eng Technol; 2009; 33(8):656-62. PubMed ID: 19848860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Type I diabetes mellitus: insulin treatment].
    Ryff AS; Berger W; Crausaz F
    Schweiz Med Wochenschr Suppl; 1994; 60():7-13. PubMed ID: 8016617
    [No Abstract]   [Full Text] [Related]  

  • 9. Induced L₂-norm minimization of glucose-insulin system for Type I diabetic patients.
    Kovács L; Benyó B; Bokor J; Benyó Z
    Comput Methods Programs Biomed; 2011 May; 102(2):105-18. PubMed ID: 20674065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes.
    Fabietti PG; Canonico V; Orsini-Federici M; Sarti E; Massi-Benedetti M
    Diabetes Technol Ther; 2007 Aug; 9(4):327-38. PubMed ID: 17705688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
    Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
    J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of glucose stimulation upon rapid pulses and ultradian oscillations of insulin secretion.
    Sturis J; O'Meara NM; Shapiro ET; Blackman JD; Tillil H; Polonsky KS; Van Cauter E
    J Clin Endocrinol Metab; 1993 Apr; 76(4):895-901. PubMed ID: 8473402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes.
    Fischer U; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Detscheff W; Lemke K
    Trans Am Soc Artif Intern Organs; 1983; 29():488-91. PubMed ID: 6673274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A framework for specifying safe behavior of the CIIP medical system.
    Babamir SM
    Adv Exp Med Biol; 2011; 696():637-44. PubMed ID: 21431605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bionic pancreas: novel perspectives on insulin replacement therapies.
    Denecke C
    Transplantation; 2015 Feb; 99(2):268-9. PubMed ID: 25651115
    [No Abstract]   [Full Text] [Related]  

  • 16. Entrainment of ultradian oscillations in the secretion of insulin and glucagon to the nonrapid eye movement/rapid eye movement sleep rhythm in humans.
    Kern W; Offenheuser S; Born J; Fehm HL
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1541-7. PubMed ID: 8636364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New technologies in the treatment of type 1 diabetes.
    Schmidt S
    Dan Med J; 2013 Nov; 60(11):B4746. PubMed ID: 24192247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meal-related insulin requirements.
    Service FJ
    Horm Metab Res Suppl; 1990; 24():77-83. PubMed ID: 2272631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morning peripheral insulin effectiveness and night changes in growth hormone, blood glucose and basal insulin needs in patients with type 1 diabetes mellitus.
    Borissova AM; Kozlovski P; Popova J; Kirilov G
    Diabete Metab; 1992; 18(6):463-4. PubMed ID: 1297604
    [No Abstract]   [Full Text] [Related]  

  • 20. Mathematical investigation of diabetically impaired ultradian oscillations in the glucose-insulin regulation.
    Huard B; Bridgewater A; Angelova M
    J Theor Biol; 2017 Apr; 418():66-76. PubMed ID: 28130099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.